- Conditions
- Plaque Type Psorisis
- Interventions
- Tapinarof Cream 1%, VTAMA®, Placebo
- Drug
- Lead sponsor
- Teva Pharmaceuticals USA
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 560 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 26
- States / cities
- Scottsdale, Arizona • Bryant, Arkansas • Dublin, California + 20 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Psoriasis
- Interventions
- Tapinarof
- Drug
- Lead sponsor
- Psoriasis Treatment Center of Central New Jersey
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023
- U.S. locations
- 1
- States / cities
- East Windsor, New Jersey
- Conditions
- Psoriasis
- Interventions
- VTAMA (tapinarof) cream, 1%
- Drug
- Lead sponsor
- Organon and Co
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023
- U.S. locations
- 10
- States / cities
- Macon, Georgia • Chicago, Illinois • Rockville, Maryland + 7 more
- Conditions
- Psoriasis
- Interventions
- VTAMA® (tapinarof) Cream 1%
- Drug
- Lead sponsor
- Organon and Co
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 7
- States / cities
- Fort Smith, Arkansas • Los Angeles, California • Boca Raton, Florida + 4 more
- Conditions
- Plaque Psoriasis
- Interventions
- Tapinarof Cream, 1%, Vtama® (Tapinarof) Cream, 1%, Placebo Control
- Drug
- Lead sponsor
- Sun Pharmaceutical Industries, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 575 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Hawthorne, New York